Cosentyx is a biologic medication that is used to treat various inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. According to the official website of Cosentyx [2], clinical studies have shown that Cosentyx is effective in reducing the symptoms of these conditions. In particular, a study published in the Journal of Rheumatology [3] found that Cosentyx was effective in treating ankylosing spondylitis, with a significant proportion of patients experiencing improvements in their symptoms.

The study found that patients who received Cosentyx experienced significant improvements in their symptoms, including reduced pain and inflammation, improved mobility, and reduced spinal stiffness. The study also found that the medication was well-tolerated, with few side effects reported.

According to Drug Patent Watch [1], Cosentyx has been approved by the FDA since 2015, and has been used by thousands of patients since then. The medication works by targeting a protein called IL-17A, which is involved in the inflammatory process that causes the symptoms of these conditions.

Overall, the available evidence suggests that Cosentyx is an effective treatment for inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. However, as with any medication, individual results may vary, and patients should discuss the potential benefits and risks of Cosentyx with their healthcare provider before starting treatment.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/ankylosing-spondylitis/faq
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422944/